Please login to the form below

Not currently logged in
Email:
Password:

basil insulin lispro

This page shows the latest basil insulin lispro news and features for those working in and with pharma, biotech and healthcare.

Lilly delays filing of Lantus rival on safety concerns

Lilly delays filing of Lantus rival on safety concerns

Eli Lilly has reined in plans to topple Sanofi's Lantus from the head of the long-acting insulin market after delaying regulatory filings for its insulin peglispro in the EU ... Lilly has said it will now file for approval of basil insulin lispro (BIL),

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics